Comparison of the efficacy of glucantime and cryotherapy simultaneously and cryotherapy alone in the treatment of cutaneous leishmaniasis

Phase 3

• Conditions: Cutaneous leishmaniasis.; Cutaneous leishmaniasis; B55.1

• Registration Number: IRCT20170723035248N4
• Lead Sponsor: Ghoum University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 November 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 476

Inclusion Criteria

Criteria for joining the study include age over one year
Onset of disease in less than 4 weeks.

Exclusion Criteria

Criteria for withdrawing from the study include use of antibiotics or other antimicrobial drugs for leishmaniasis in the past 4 weeks
Extensive lesions with a diameter of more than 5 cm and more than 3 lesions on the patient's body.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
En measuring surface of healed tissue of people with cutaneous leishmaniasis. Timepoint: Six weeks after the last treatment in both groups, skin lesions are assessed. Method of measurement: Calibrated ruler.

Secondary Outcome Measures

Name	Time	Method
Elimination of inflammatory symptoms and tissue hardness and healing of papules and ulcers are considered as complete recovery. Timepoint: Six weeks after the last treatment. Method of measurement: Calibrated ruler.